Should the use of omeprazole be allowed during equestrian competition?

Prioritising equine welfare, making evidenced-based policy, and consistent decision-making across sports are crucial to maintaining the social licence for equestrian sport. Regulations on the use of omeprazole during competition differ; all regulators argue that their rules prioritise welfare. This...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Equine veterinary journal 2024-07
Hauptverfasser: Campbell, Madeleine L H, Sykes, Benjamin W
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Equine veterinary journal
container_volume
creator Campbell, Madeleine L H
Sykes, Benjamin W
description Prioritising equine welfare, making evidenced-based policy, and consistent decision-making across sports are crucial to maintaining the social licence for equestrian sport. Regulations on the use of omeprazole during competition differ; all regulators argue that their rules prioritise welfare. This discrepancy is a matter of concern to the public and equestrian stakeholders. To apply Campbell's Ethical Framework for the use of Horses in Sport to the question: 'Should the use of omeprazole be allowed during equestrian competition?' A desk-based ethico-legal study. Campbell's Ethical Framework for the Use of Horses in Sport was applied in a stepwise fashion: definition of the ethical question; analysis of the evidence base; consideration of stakeholders' interests; harm:benefit analysis; application of the three central tenets of the framework, and formulation of conclusions and recommendations. Stakeholders in equine sports have a variety of (frequently conflicting) interests; all of them share an interest in optimising equine welfare. The incidence of EGUS in competition horses is high. Omeprazole is a cornerstone treatment. There are currently discrepancies in regulation about the use of omeprazole during competitions. Recent evidence suggests that withholding omeprazole treatment for two clear days before competition allows the recurrence of squamous EGUS, whereas withholding treatment on the day of competition only does not have that effect. The current state of scientific knowledge about the use of omeprazole in horses. The analysis did not consider possible health and thus welfare effects of the out-of-competition treatment with omeprazole. Based on recent scientific evidence, if horses are being treated with omeprazole outside of competition then treatment on the day of competition should be permitted on welfare grounds. Revision of regulations around the use of omeprazole during competition by governing bodies is necessary to safeguard the ethical use of horses in sport.
doi_str_mv 10.1111/evj.14129
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3079175136</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3079175136</sourcerecordid><originalsourceid>FETCH-LOGICAL-c210t-17ca3f0b481531902a106383ebe3b234c421612e1196ab9edad3ab4873a255d43</originalsourceid><addsrcrecordid>eNo9kMtOwzAQRS0EoqWw4AeQl7BI8Xic1wqhigJSJRbAOnLiCU2VxMFOQPD1hLYwmzuLo6urw9g5iDmMd00fmzkokOkBm0qhZIAookM2Hd8wgEipCTvxfiMEolTymE0wSVMVJmLKls9rO9SG92vigyduS24b6pz-tjXxnLiua_tJhpvBVe0bp_eBfO8q3fLCNh31VV_Z9uaUHZW69nS2zxl7Xd69LB6C1dP94-J2FRQSRB9AXGgsRa4SCBFSITWICBOknDCXqAolIQJJAGmk85SMNqhHOkYtw9AonLHLXW_n7HZJ1lS-oLrWLdnBZyjiFOIQMBrRqx1aOOu9ozLrXNVo95WByH61ZaO2bKttZC_2tUPekPkn_zzhD--fZ0A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3079175136</pqid></control><display><type>article</type><title>Should the use of omeprazole be allowed during equestrian competition?</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Campbell, Madeleine L H ; Sykes, Benjamin W</creator><creatorcontrib>Campbell, Madeleine L H ; Sykes, Benjamin W</creatorcontrib><description>Prioritising equine welfare, making evidenced-based policy, and consistent decision-making across sports are crucial to maintaining the social licence for equestrian sport. Regulations on the use of omeprazole during competition differ; all regulators argue that their rules prioritise welfare. This discrepancy is a matter of concern to the public and equestrian stakeholders. To apply Campbell's Ethical Framework for the use of Horses in Sport to the question: 'Should the use of omeprazole be allowed during equestrian competition?' A desk-based ethico-legal study. Campbell's Ethical Framework for the Use of Horses in Sport was applied in a stepwise fashion: definition of the ethical question; analysis of the evidence base; consideration of stakeholders' interests; harm:benefit analysis; application of the three central tenets of the framework, and formulation of conclusions and recommendations. Stakeholders in equine sports have a variety of (frequently conflicting) interests; all of them share an interest in optimising equine welfare. The incidence of EGUS in competition horses is high. Omeprazole is a cornerstone treatment. There are currently discrepancies in regulation about the use of omeprazole during competitions. Recent evidence suggests that withholding omeprazole treatment for two clear days before competition allows the recurrence of squamous EGUS, whereas withholding treatment on the day of competition only does not have that effect. The current state of scientific knowledge about the use of omeprazole in horses. The analysis did not consider possible health and thus welfare effects of the out-of-competition treatment with omeprazole. Based on recent scientific evidence, if horses are being treated with omeprazole outside of competition then treatment on the day of competition should be permitted on welfare grounds. Revision of regulations around the use of omeprazole during competition by governing bodies is necessary to safeguard the ethical use of horses in sport.</description><identifier>ISSN: 0425-1644</identifier><identifier>ISSN: 2042-3306</identifier><identifier>EISSN: 2042-3306</identifier><identifier>DOI: 10.1111/evj.14129</identifier><identifier>PMID: 38994580</identifier><language>eng</language><publisher>United States</publisher><ispartof>Equine veterinary journal, 2024-07</ispartof><rights>2024 The Author(s). Equine Veterinary Journal published by John Wiley &amp; Sons Ltd on behalf of EVJ Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c210t-17ca3f0b481531902a106383ebe3b234c421612e1196ab9edad3ab4873a255d43</cites><orcidid>0000-0002-0505-6228 ; 0000-0003-1123-5828</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38994580$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Campbell, Madeleine L H</creatorcontrib><creatorcontrib>Sykes, Benjamin W</creatorcontrib><title>Should the use of omeprazole be allowed during equestrian competition?</title><title>Equine veterinary journal</title><addtitle>Equine Vet J</addtitle><description>Prioritising equine welfare, making evidenced-based policy, and consistent decision-making across sports are crucial to maintaining the social licence for equestrian sport. Regulations on the use of omeprazole during competition differ; all regulators argue that their rules prioritise welfare. This discrepancy is a matter of concern to the public and equestrian stakeholders. To apply Campbell's Ethical Framework for the use of Horses in Sport to the question: 'Should the use of omeprazole be allowed during equestrian competition?' A desk-based ethico-legal study. Campbell's Ethical Framework for the Use of Horses in Sport was applied in a stepwise fashion: definition of the ethical question; analysis of the evidence base; consideration of stakeholders' interests; harm:benefit analysis; application of the three central tenets of the framework, and formulation of conclusions and recommendations. Stakeholders in equine sports have a variety of (frequently conflicting) interests; all of them share an interest in optimising equine welfare. The incidence of EGUS in competition horses is high. Omeprazole is a cornerstone treatment. There are currently discrepancies in regulation about the use of omeprazole during competitions. Recent evidence suggests that withholding omeprazole treatment for two clear days before competition allows the recurrence of squamous EGUS, whereas withholding treatment on the day of competition only does not have that effect. The current state of scientific knowledge about the use of omeprazole in horses. The analysis did not consider possible health and thus welfare effects of the out-of-competition treatment with omeprazole. Based on recent scientific evidence, if horses are being treated with omeprazole outside of competition then treatment on the day of competition should be permitted on welfare grounds. Revision of regulations around the use of omeprazole during competition by governing bodies is necessary to safeguard the ethical use of horses in sport.</description><issn>0425-1644</issn><issn>2042-3306</issn><issn>2042-3306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kMtOwzAQRS0EoqWw4AeQl7BI8Xic1wqhigJSJRbAOnLiCU2VxMFOQPD1hLYwmzuLo6urw9g5iDmMd00fmzkokOkBm0qhZIAookM2Hd8wgEipCTvxfiMEolTymE0wSVMVJmLKls9rO9SG92vigyduS24b6pz-tjXxnLiua_tJhpvBVe0bp_eBfO8q3fLCNh31VV_Z9uaUHZW69nS2zxl7Xd69LB6C1dP94-J2FRQSRB9AXGgsRa4SCBFSITWICBOknDCXqAolIQJJAGmk85SMNqhHOkYtw9AonLHLXW_n7HZJ1lS-oLrWLdnBZyjiFOIQMBrRqx1aOOu9ozLrXNVo95WByH61ZaO2bKttZC_2tUPekPkn_zzhD--fZ0A</recordid><startdate>20240712</startdate><enddate>20240712</enddate><creator>Campbell, Madeleine L H</creator><creator>Sykes, Benjamin W</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0505-6228</orcidid><orcidid>https://orcid.org/0000-0003-1123-5828</orcidid></search><sort><creationdate>20240712</creationdate><title>Should the use of omeprazole be allowed during equestrian competition?</title><author>Campbell, Madeleine L H ; Sykes, Benjamin W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c210t-17ca3f0b481531902a106383ebe3b234c421612e1196ab9edad3ab4873a255d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Campbell, Madeleine L H</creatorcontrib><creatorcontrib>Sykes, Benjamin W</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Equine veterinary journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Campbell, Madeleine L H</au><au>Sykes, Benjamin W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Should the use of omeprazole be allowed during equestrian competition?</atitle><jtitle>Equine veterinary journal</jtitle><addtitle>Equine Vet J</addtitle><date>2024-07-12</date><risdate>2024</risdate><issn>0425-1644</issn><issn>2042-3306</issn><eissn>2042-3306</eissn><abstract>Prioritising equine welfare, making evidenced-based policy, and consistent decision-making across sports are crucial to maintaining the social licence for equestrian sport. Regulations on the use of omeprazole during competition differ; all regulators argue that their rules prioritise welfare. This discrepancy is a matter of concern to the public and equestrian stakeholders. To apply Campbell's Ethical Framework for the use of Horses in Sport to the question: 'Should the use of omeprazole be allowed during equestrian competition?' A desk-based ethico-legal study. Campbell's Ethical Framework for the Use of Horses in Sport was applied in a stepwise fashion: definition of the ethical question; analysis of the evidence base; consideration of stakeholders' interests; harm:benefit analysis; application of the three central tenets of the framework, and formulation of conclusions and recommendations. Stakeholders in equine sports have a variety of (frequently conflicting) interests; all of them share an interest in optimising equine welfare. The incidence of EGUS in competition horses is high. Omeprazole is a cornerstone treatment. There are currently discrepancies in regulation about the use of omeprazole during competitions. Recent evidence suggests that withholding omeprazole treatment for two clear days before competition allows the recurrence of squamous EGUS, whereas withholding treatment on the day of competition only does not have that effect. The current state of scientific knowledge about the use of omeprazole in horses. The analysis did not consider possible health and thus welfare effects of the out-of-competition treatment with omeprazole. Based on recent scientific evidence, if horses are being treated with omeprazole outside of competition then treatment on the day of competition should be permitted on welfare grounds. Revision of regulations around the use of omeprazole during competition by governing bodies is necessary to safeguard the ethical use of horses in sport.</abstract><cop>United States</cop><pmid>38994580</pmid><doi>10.1111/evj.14129</doi><orcidid>https://orcid.org/0000-0002-0505-6228</orcidid><orcidid>https://orcid.org/0000-0003-1123-5828</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0425-1644
ispartof Equine veterinary journal, 2024-07
issn 0425-1644
2042-3306
2042-3306
language eng
recordid cdi_proquest_miscellaneous_3079175136
source Wiley Online Library Journals Frontfile Complete
title Should the use of omeprazole be allowed during equestrian competition?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T08%3A45%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Should%20the%20use%20of%20omeprazole%20be%20allowed%20during%20equestrian%20competition?&rft.jtitle=Equine%20veterinary%20journal&rft.au=Campbell,%20Madeleine%20L%20H&rft.date=2024-07-12&rft.issn=0425-1644&rft.eissn=2042-3306&rft_id=info:doi/10.1111/evj.14129&rft_dat=%3Cproquest_cross%3E3079175136%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3079175136&rft_id=info:pmid/38994580&rfr_iscdi=true